PLRX
Price
$1.38
Change
-$0.09 (-6.12%)
Updated
Jun 13 closing price
Capitalization
84.71M
57 days until earnings call
SRRK
Price
$32.45
Change
-$0.87 (-2.61%)
Updated
Jun 13 closing price
Capitalization
3.08B
52 days until earnings call
Interact to see
Advertisement

PLRX vs SRRK

Header iconPLRX vs SRRK Comparison
Open Charts PLRX vs SRRKBanner chart's image
Pliant Therapeutics
Price$1.38
Change-$0.09 (-6.12%)
Volume$561.22K
Capitalization84.71M
Scholar Rock Holding
Price$32.45
Change-$0.87 (-2.61%)
Volume$646.48K
Capitalization3.08B
PLRX vs SRRK Comparison Chart
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLRX vs. SRRK commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a Hold and SRRK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (PLRX: $1.38 vs. SRRK: $32.45)
Brand notoriety: PLRX and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 62% vs. SRRK: 54%
Market capitalization -- PLRX: $84.71M vs. SRRK: $3.08B
PLRX [@Biotechnology] is valued at $84.71M. SRRK’s [@Biotechnology] market capitalization is $3.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, SRRK is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 4 TA indicator(s) are bullish while SRRK’s TA Score has 4 bullish TA indicator(s).

  • PLRX’s TA Score: 4 bullish, 5 bearish.
  • SRRK’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both PLRX and SRRK are a bad buy in the short-term.

Price Growth

PLRX (@Biotechnology) experienced а -15.34% price change this week, while SRRK (@Biotechnology) price change was -5.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

PLRX is expected to report earnings on Aug 11, 2025.

SRRK is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($3.08B) has a higher market cap than PLRX($84.7M). SRRK YTD gains are higher at: -24.919 vs. PLRX (-89.522). PLRX has higher annual earnings (EBITDA): -214.08M vs. SRRK (-268.99M). SRRK has more cash in the bank: 364M vs. PLRX (306M). PLRX (60.2M) and SRRK (63.1M) have identical debt. PLRX (0) and SRRK (0) have equivalent revenues.
PLRXSRRKPLRX / SRRK
Capitalization84.7M3.08B3%
EBITDA-214.08M-268.99M80%
Gain YTD-89.522-24.919359%
P/E RatioN/AN/A-
Revenue00-
Total Cash306M364M84%
Total Debt60.2M63.1M95%
FUNDAMENTALS RATINGS
SRRK: Fundamental Ratings
SRRK
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
77
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PLRXSRRK
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend about 1 month ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 25 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BTGD36.60-0.09
-0.25%
STKd 100% Bitcoin & 100% Gold ETF
AIEQ40.80-0.40
-0.98%
Amplify AI Powered Equity ETF
VOTE70.25-0.73
-1.02%
TCW Transform 500 ETF
PALC47.68-0.52
-1.08%
Pacer Lunt Large Cap Mlt Ftr Alt ETF
DSI112.20-1.53
-1.35%
iShares ESG MSCI KLD 400 ETF

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with LXRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-6.12%
LXRX - PLRX
41%
Loosely correlated
-3.49%
SRRK - PLRX
40%
Loosely correlated
-2.61%
OCUL - PLRX
40%
Loosely correlated
-2.46%
RIGL - PLRX
38%
Loosely correlated
-3.66%
CRGX - PLRX
37%
Loosely correlated
-2.01%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with PLRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
-2.61%
PLRX - SRRK
40%
Loosely correlated
-6.12%
SNDX - SRRK
39%
Loosely correlated
-3.94%
VTGN - SRRK
39%
Loosely correlated
-4.54%
ALT - SRRK
37%
Loosely correlated
-3.22%
AVXL - SRRK
37%
Loosely correlated
-2.31%
More